VectorBuilder's partner, Ucello, announced that its CD19-targeting umbilical cord blood-derived allogeneic CAR-T cell therapy, UC101, received Investigational New Drug (IND) approval from the U.S.
Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. Impaired insulin receptor signaling is ...
For ELF3 overexpression by lentivirus in MCF10A, human ELF3 was subcloned into the pCDH-CMV-MCS-EF1- puro vector, which was a kind gift from Yin lab. Myc-tagged human E2F6 was subcloned into the pDEST ...
Recombinant adeno-associated virus (AAV) and lentiviral vectors (LV) are vehicles for direct delivery of therapeutic ... In this talk, we present optimization strategies for the transfection step of ...
Confluent cultures of WT and Cx43-null astrocytes were transduced with lentiviral particles containing hTERT cDNA 9 × 10 5 transduction ... 15070063). Two hours prior to transfection, the media was ...
Briefly, pTRIPZ shRNA anti-Chk1 constructs, pTRIPZ Inducible Lentiviral non-silencing shRNA Control (Cat n° RHS4743), pLEX p53R248Q-EGFP, pTRIPz-p53-EGFP transfer vectors and their respective empty ...